These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 13379678)

  • 1. [Anticoagulant 3-(1-phenyl-propyl)-4-hydroxycoumarin in the treatment of phlebothrombosis and thrombophlebitis].
    PERCESEPE E
    Rass Int Clin Ter; 1956 Jul; 36(14):419-24. PubMed ID: 13379678
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
    SCHIAVINA GP
    Minerva Ginecol; 1953 Feb; 5(3):20-1. PubMed ID: 13063225
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ambulatory anticoagulant therapy with 3-(l-phenylpropyl)-4-hydroxycoumarin].
    KNOBEL P
    Praxis; 1956 Jan; 45(4):65-72. PubMed ID: 13310434
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phenylpropyl hydroxycoumarin as anticoagulant in obstetric and gynecological thrombophlebitis and its antidote, vitamin K1].
    DE DOMINICIS E; ROLANDI L
    Riv Ostet Ginecol Prat; 1955 Nov; 37(11):658-65. PubMed ID: 13281402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Derivative of 4-hydroxycoumarin as a new anticoagulant].
    KLOSA J
    Pharmazie; 1954 Aug; 9(8):622. PubMed ID: 13224346
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350].
    LEROUX M; JAMAIN B
    Therapie; 1956; 11(1):85-101. PubMed ID: 13337762
    [No Abstract]   [Full Text] [Related]  

  • 7. New anticoagulant for oral use-3-(1'-phenylpropyl)-4 hydroxycoumarin (liquamar); its evaluation for short-term therapy.
    GOLD H; LILLEY GW
    J Am Med Assoc; 1959 Jul; 170(11):1303-6. PubMed ID: 13664522
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical data on anticoagulant treatment with 3-(1-phenylpropy1)-4-hydroxycoumarin].
    VERGANI G
    Gazz Med Ital; 1955 Dec; 114(12):269-73. PubMed ID: 13305779
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new anticoagulant: 3-(1-phenylpropyl)4-hydroxycoumarin; early clinical results].
    VAN WIEN A; VEROFT R
    Acta Clin Belg; 1953; 8(6):618-28. PubMed ID: 13137838
    [No Abstract]   [Full Text] [Related]  

  • 10. Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.
    BOURGAIN R; TODD M; HERZIG L; WRIGHT IS
    Circulation; 1954 Nov; 10(5):680-4. PubMed ID: 13209748
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of acenocoumarin, a new 4-hydroxycoumarin anticoagulant.
    SCHILLING FJ; KRUESI OR
    Am J Med Sci; 1956 May; 231(5):558-63. PubMed ID: 13313541
    [No Abstract]   [Full Text] [Related]  

  • 12. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
    BARKER NW; HANSON HH; MANN FD
    J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
    [No Abstract]   [Full Text] [Related]  

  • 13. [Independent hypoprothrombinemic action of anticoagulants derived from 4-hydroxycoumarin].
    DERECHIN M
    Prensa Med Argent; 1956 May; 43(20):1644. PubMed ID: 13370465
    [No Abstract]   [Full Text] [Related]  

  • 14. [Coagulatory and histomorphological modifications induced by 3-(1-phenyl-propyl)-4-hydroxycoumarin; experimental study].
    SALVI F
    Riv Anat Patol Oncol; 1954 May; 8(4):569-602. PubMed ID: 13225432
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the anticoagulant action of 3-(alpha-p-chlorphenyl-beta-acetylethyl)-4-hydroxycoumarin (coumachlor) and dicoumarol in chicks and rats.
    DAM H; SØNDERGAARD E
    Acta Pharmacol Toxicol (Copenh); 1953; 9(2):137-47. PubMed ID: 13079850
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new assymetrical vitamin K antagonist: 3-(alpha-naphthyl)-4-hydroxycoumarin].
    MORAUX J; MEUNIER P; MENTZER C
    Arch Int Pharmacodyn Ther; 1953 May; 94(1):47-64. PubMed ID: 13066148
    [No Abstract]   [Full Text] [Related]  

  • 17. [Remarks on P. Bockel and K. D. Schmidt's paper Accident in anticoagulant therapy].
    SARTORI C
    Munch Med Wochenschr; 1955 Sep; 97(37):1219-20. PubMed ID: 13265728
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombophlebitis and phlebothrombosis; with special reference to dicumarol and heparin treatment.
    CLEMENTS JL
    J Med Assoc Ga; 1947 Jun; 36(6):217-23. PubMed ID: 20242849
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of 4-hydroxycoumarin anticoagulant no. 63.
    ROTTER R; MEYER OO
    J Lab Clin Med; 1950 Dec; 36(6):981-2. PubMed ID: 14795070
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of 4-hydroxycoumarin anticoagulant No. 63.
    ROTTER R; MEYER OO
    AMA Arch Intern Med; 1951 Sep; 88(3):296-309. PubMed ID: 14856458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.